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The embryonic stem cell differentiation system was
used to define the roles of the Activin/Nodal, BMP,
and canonical Wnt signaling pathways at three dis-
tinct developmental stages during hematopoietic on-
togeny: induction of a primitive streak-like popula-
tion, formation of Flk1+ mesoderm, and induction of
hematopoietic progenitors. Activin/Nodal and Wnt,
but not BMP, signaling are required for the induction
of the primitive streak. Although BMP is not required
for primitive streak induction, it displays a strong
posteriorizing effect on this population. All three
signaling pathways regulate induction of Flk1+meso-
derm. The specification of Flk1+mesoderm to the he-
matopoietic lineages requires VEGF andWnt, but not
BMP or Activin/Nodal signaling. Specifically, Wnt
signaling is essential for commitment of the primitive
erythroid, but not the definitive lineages. These find-
ings highlight dynamic changes in signaling require-
ments during blood cell development and identify
a role for Wnt signaling in the establishment of the
primitive erythroid lineage.
INTRODUCTION
The establishment of the hematopoietic system involvesmultiple
developmental steps ranging from induction and patterning of
mesoderm to specification of the earliest blood cell progenitors.
Mesoderm is formed during gastrulation from undifferentiated
epiblast cells as they transit through the primitive streak (PS)
(Tam and Behringer, 1997). The first mesodermal cells to be
induced migrate proximally through extraembryonic tissue
where they undergo specification to the hematopoietic and vas-
cular lineages at approximately embryonic day 7.5, giving rise to
the blood islands of the yolk sac (Moore and Metcalf, 1970; Palis
et al., 1999). The predominant hematopoietic cells in the blood
islands are known as primitive erythrocytes and are distin-
guished by their large size, by their production of an embryonic
spectrum of globin chains, and by the fact that they retain their
nuclei after entry into circulation. In addition to the primitive
erythroid lineage, the mouse yolk sac also generates definitive60 Cell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc.erythroid and myeloid progenitors (Dieterlen-Lievre, 1975; Palis
et al., 1999).
The developmental progression from PS formation through
mesoderm induction to hematopoietic specification can be
mapped, to some extent, by the expression of genes indica-
tive of each individual stage. The formation of the PS is de-
fined by the upregulation of brachyury, a conserved T box
transcription factor that is expressed throughout this structure
in diverse organisms, including Xenopus, zebrafish, and mam-
mals (Kispert and Herrmann, 1994; Schute-Merker et al., 1997;
Smith et al., 1991). Lineage tracing and reporter studies as
well as in situ analyses have shown that expression of the re-
ceptor kinase Flk1 (VEGFR-2) is associated with the next de-
velopmental stage: the induction and patterning of distinct
subsets of mesoderm, including those fated to the hematopoi-
etic, vascular, and some cardiac and somitic precursors (Ema
et al., 2006; Motoike et al., 2003). As mesoderm is specified to
the hematopoietic lineages, Flk1 expression diminishes while
CD41 expression increases. CD41 is expressed on all embry-
onic hematopoietic progenitors, although levels on the primi-
tive erythroid progenitors are somewhat lower than those of
the definitive lineages (Ferkowicz et al., 2003; Mikkola et al.,
2003).
To understand the signaling pathways regulating the estab-
lishment of the hematopoietic system, it is necessary to focus
on each specific stage independently, as critical inductive fac-
tors such as those from the TGFb and Wnt families are known
to display different functions on different cell populations.
Studies using a variety of model systems have shown that
Nodal and Wnt signaling are required for the proper formation
of the PS and subsequent induction of mesoderm and endo-
derm (Conlon et al., 1994; Liu et al., 1999). The role of the
BMP pathway on PS formation is less clear. Targeting studies
have shown that all BMP receptor 2 (bmpr2) null mice and
a subpopulation of those deficient in either BMP receptor 1a
(bmpr1a) or bmp4 fail to undergo gastrulation, suggesting
a role for BMP signaling at this early stage (Beppu et al.,
2000; Mishina et al., 1995; Winnier et al., 1995). In contrast
to these observations, conditional inactivation of bmpr1a in
the epiblast did not impact gastrulation, suggesting that BMP
signaling may not be required for this process (Miura et al.,
2006). The differences in these studies may be related to
stage-specific requirements for this pathway in early develop-
ment or due to compensatory functions of the bmpr1b in the
latter study. Although these different models have defined
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the induction of Flk1+ mesoderm and its specification to the
hematopoietic lineage. Insights into the regulation of this devel-
opmental step have been provided by studies using the ES cell
model that showed that BMP4 and Activin A, a nodal surrogate
(Tada et al., 2005), can induce the formation of a Flk1+ popu-
lation in developing embryoid bodies (EBs) in serum-free cul-
tures (Park et al., 2004). However, as no distinction was
made between PS formation and Flk1+ mesoderm induction,
it is difficult to determine the specific target populations for
these factors. Progression of Flk1+ mesoderm to the hemato-
poietic lineage is also poorly understood. The studies of Park
et al. did show that the interaction of VEGF with Flk1 was im-
portant for this specification step. Whether or not other factors
are involved at this stage remains to be determined. To further
elucidate the regulatory pathways that control hematopoietic
specification from ES cells, we have evaluated the combined
roles of Activin/Nodal, Wnt, and BMP signaling in this process
at discrete developmental stages. The findings from these
studies indicate that Activin/Nodal and Wnt, but not BMP4,
are required for PS formation, whereas all three factors ap-
peared to function in the induction of Flk1+ mesoderm. As ob-
served previously, hematopoietic specification of the Flk1+ me-
soderm was dependent on VEGF/Flk1 signaling. Although BMP
and Activin/Nodal signaling did not appear to impact this de-
velopmental stage, our studies uncovered an essential role
for Wnt signaling in the specification of the primitive erythroid
lineage from Flk1+ mesoderm. These findings highlight the
power of the ES cell model in mapping regulatory pathways
that control embryonic lineage commitment and in identifying
lineage regulators that would be difficult to identify in the early
embryo.
RESULTS
To define the key signaling pathways that regulate hematopoi-
etic commitment in ES cell differentiation cultures, we examined
three distinct developmental stages representing (1) the induc-
tion of a PS-like population, (2) the commitment of the PS-like
population to Flk1+ mesoderm, and (3) the specification of
Flk1+ mesoderm to the hematopoietic lineage (Figure 1). For
these studies, we used an ES cell line with the green fluorescent
protein (GFP) cDNA targeted to the brachyury locus (GFP-Bry)
and the human CD4 cDNA targeted to the foxa2 locus (CD4-
Foxa2) (Gadue et al., 2006) and focused our analysis on the
BMP,Wnt, and Activin/Nodal/TGFb pathways. ES cells were dif-
Figure 1. Schematic of Hematopoietic De-
velopment Depicting the Stages of Devel-
opment Analyzed in This Study
ferentiated as EBs in the presence of the
indicated inducers in the absence of fetal
calf serum. Our previous studies have
demonstrated that PS formation and
germ layer induction in the EBs in the
presence of appropriate inducers accu-
rately recapitulates these developmental steps as they happen
in the early embryo (Gadue et al., 2006).
Stage 1: The Role of BMP Signaling in ES Cell-Derived
PS Induction
We recently demonstrated that the induction of a PS-like popu-
lation in ES cell differentiation cultures requires both Wnt and
Activin/Nodal/TGFb signaling, findings consistent with the re-
quirement of these pathways in the establishment of the PS in
the early embryo (Gadue et al., 2006). In addition to these path-
ways, targeting studies in mice suggest that BMP signaling may
also play a role in the formation of the PS (Beppu et al., 2000;
Mishina et al., 1995; Winnier et al., 1995). To evaluate the role
of BMP signaling in PS formation in the ES cell model, ES cells
were differentiated with BMP4 alone or with BMP4 and DKK1
or SB-431542 (SB), inhibitors of Wnt and Activin/Nodal/TGFb
signaling, respectively (Inman et al., 2002; Semenov et al.,
2001). The concentration of inhibitors used was based on their
ability to completely inhibit the induction of CD4-Foxa2 and
GFP-Bry by exogenously added Activin A or Wnt3a (Figure S1
available online). When added to ES cell differentiation cultures
in the absence of other factors, BMP4 induced a GFP-Bry pop-
ulation (GFP-Bry+/CD4-Foxa2lo/) that appeared to represent
the posterior PS (Figure 2A). The BMP-induced population ex-
pressed high levels of the posterior PS markers hoxB1 and
mesp1 (Gadue et al., 2006; Saga et al., 1996) and low levels of
the anterior markers chrd and cer1 (Bachiller et al., 2000; Gadue
et al., 2006) (Figures 2B and 2C). To determine if theWnt and Ac-
tivin/Nodal/TGFb signaling pathways are involved in the forma-
tion of the BMP-induced GFP-Bry+ population, DKK1 or SB
was added together with BMP4 to the differentiation cultures.
The addition of either inhibitor completely blocked the develop-
ment of the BMP4-induced posterior streak population
(Figure 2A). As expected, expression of other PS markers,
including hoxb1 and mesp1, was also inhibited by addition of
DKK1 and SB to the cultures (Figure 2B). These findings demon-
strate that the induction of the GFP-Bry+/CD4-Foxa2lo/ popula-
tion by BMP4 is dependent on bothWnt and Activin/Nodal/TGFb
signaling and suggest that BMP4 functions through the upregu-
lation of factors from both pathways at this stage of develop-
ment. To determine if this is the case, BMP4-induced popula-
tions were analyzed for expression of wnt3 and nodal. As
shown in Figure 2D, genes encoding these cytokines were
induced by BMP4.
To examine the interplay between BMP, Activin/Nodal, and
Wnt signaling in PS induction, ES cells were differentiated in
the presence of Activin A and low concentrations of Wnt3aCell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc. 61
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ES cells were differentiated as EBs for 4 days in serum-free media in the presence of BMP4 (0.3 ng/ml), Activin A (2 ng/ml), DKK1 (300 ng/ml), SB-431542 (6 uM),
Wnt3a (3 ng/ml), and BMPR1A-Fc plus BMPR1B-Fc (500 ng/ml each) as indicated.
(A) Flow cytometric analysis of day 4 EBs.
(B–D) Quantitative RT-PCR gene expression analysis of ES cells differentiated in (A). Average expression normalized to actb is shown. (B and C) Numbers on
vertical axis represent expression levels relative to Activin A and Wnt3a-treated samples. (B) Expression of posterior PS markers. (C) Expression of anterior
PS markers. (D) Expression of nodal and wnt3 after BMP induction.
(E) Flow cytometric analysis of intracellular-phosphorylated Smad1/5 in day 4 EBs inducedwith the indicated combinations of factors. Filled histograms represent
anti-GST control; open histograms are cells stained with anti-phospho-Smad1/5. Errors bars indicate ± SEM (n = 3). (Act, Activin A; R, BMPR1A-Fc and
BMPR1B-Fc; SB, SB-431542; and Stim, minus stimulation).together with either BMP4 or BMPR1A-Fc and BMPR 1B-Fc fu-
sion proteins, which are inhibitors of BMP signaling (Natsume
et al., 1997). As shown previously, the combination of Activin A
and Wnt3a efficiently induced a PS-like population that ex-62 Cell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc.pressed GFP-Bry together with a broad range of CD4-Foxa2 ex-
pression (Figure 2A) (Gadue et al., 2006). The addition of BMP4
with Activin A and Wnt3a enhanced GFP-Bry induction but
completely inhibited the development of the anterior streak
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(A) ES cells differentiated as in Figure 2 were analyzed for Flk1 versus Brachyury expression by flow cytometry at day 4 of differentiation.
(B andC) ES cells were differentiated for 4 dayswith Activin A (2 ng/ml),Wnt3a (3 ng/ml), andBMP4 (0.3 ng/ml), and the resultingGFP-Bry+/Flk1 orGFP-Bry+/Flk1+
populations were isolated by cell sorting. These populations were reaggregated in serum-free media in the presence and absence of Activin A (10 ng/ml). (B) Flow
cytometric analysis of CD4-Foxa2 and CD31 expression on these reaggregated populations after 2 or 3 days of culture. (C) Gene expression analysis from
the samples in B by RT-PCR. (n = 3) (Act, Activin A; R, BMPR1A-Fc and BMPR1B-Fc; SB, SB-431542; Stim, minus stimulation; and Rg, reaggregation).CD4-Foxa2hi subpopulation, suggesting that the BMP pathway
exerts a dominant effect in promoting posterior streak formation
(Figure 2A). In addition to Foxa2, chrd and cer1 were also down-
regulated, whereas the posterior markers mesp1 and hoxB1
were enhanced by BMP4 treatment (Figures 2B and 2C). The
dominant effect of BMP4 was blocked by the addition of the
BMP inhibitors to the cultures (+BMP&R). Addition of the soluble
BMPRs to the Activin A/Wnt3a-induced cultures (+R) had no dis-
cernable effect on the development of the GFP-Bry/CD4-Foxa2
population or on the expression of other PSmarkers (Figures 2A–
2C). To confirm that BMP signaling was efficiently inhibited by
the addition of the soluble receptors, we evaluated the level of
phosphorylation of Smad1 and/or Smad5, mediators of BMP
signaling (Derynck and Zhang, 2003), by intracellular flow cytom-
etry. As shown in Figure 2E, the addition of BMP4 to the Activin A
and Wnt3a-induced cultures resulted in a robust phospho-Smad1/5 signal, which was completely inhibited by the addition
of the soluble BMPRs. Taken together, these findings clearly
demonstrate that BMP signaling is not required for the develop-
ment of the PS population in ES cell differentiation cultures. They
also show that BMP exerts a dominant effect over Activin A
and Wnt3a in promoting the formation of the posterior streak
population.
Flk1 Induced by BMP Signaling Is a Marker
of Hematopoietic Mesoderm Commitment
As Flk1 has been shown to represent one of the earliest markers
of prehematopoietic mesoderm, we next evaluated its expres-
sion on ES cells induced with BMP4, Activin A, and Wnt3a as
in Figure 2. Induction with BMP4 alone resulted in the develop-
ment of a Flk1+ population, a finding consistent with previous
studies of Park et al. (2004) (Figure 3A). As expected, theCell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc. 63
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(A) Schematic representation of the stages of development analyzed and the assays used for the evaluation of Flk1+ mesoderm development. GFP-Bry+/Flk1
cells were isolated from day 4 EBs differentiated in the presence of Activin A (2 ng/ml) and Wnt3a (3–5 ng/ml). These PS cells were reaggregated for 24 hr with64 Cell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc.
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by the addition of either DKK1 or SB given that both pathways
are required for PS formation, the stage prior to the onset of
Flk1 expression. Activin A and low levels of Wnt3a did not induce
substantial levels of Flk1 expression, and the combination of the
three factors did not induce a larger Flk1+ population than BMP4
alone. Flk1 expression at this stage was completely inhibited by
the addition of the soluble BMPRs (Figure 3A). These observa-
tions indicate that BMP4 signaling is important for the
induction of Flk1 at this stage of development. To be able to
use Flk1 as a marker of committed mesoderm, it is essential to
demonstrate that the fate of this population is fixed with respect
to germ layer potential. We have previously shown that the Acti-
vin A/Wnt3a-generated GFP-Bry+/Foxa2lo posterior streak-like
population can be induced to form endoderm by treatment
with high levels of Activin A (Gadue et al., 2006), indicating that
this population is not fully committed to the mesoderm lineage.
To determine if the Flk1+ population can still undergo conversion
to an endoderm fate, GFP-Bry+/Flk1+ or GFP-Bry+/Flk1 cells in-
duced with the combination of Activin A, Wnt3a, and BMP4were
isolated by cell sorting and reaggregated in the presence or ab-
sence of Activin A for 2 or 3 days. After this time, the aggregates
were harvested, dissociated, and analyzed for the expression of
CD4-Foxa2, sox17, foxa3, pdx1, and hnf4a as a measure of en-
doderm potential and CD31 as a marker of mesoderm (Albelda
et al., 1991; Friedman and Kaestner, 2006; Gadue et al., 2006;
Kanai-Azuma et al., 2002). When cultured for 2 or 3 days with
Activin A, the majority of the cells derived from the GFP-Bry+/
Flk1 fraction expressed high levels of CD4-Foxa2 (Figure 3B).
This population also expressed the above spectrum of endo-
derm genes, suggesting that it had undergone commitment to
endoderm (Figure 3C). In contrast, the GFP-Bry+/Flk1+-derived
population did not upregulate CD4-Foxa2 or any other genes
indicative of endoderm development (Figures 3B and 3C).
Rather, these cells generated a significant CD31+ population
after culture with Activin A, suggesting that they underwent mat-
uration to the endothelial lineage (Figure 3B). The outcome of
these studies strongly suggests that upregulation of Flk1 is
indicative of a mesoderm commitment step, in that the popula-
tion is no longer able to generate endoderm in response to
Activin A. As Flk1 is expressed on all posterior mesoderm that
gives rise to the yolk sac blood islands (Ema et al., 2006), our
findings demonstrate that Flk1 provides a valid marker for
monitoring hematopoietic mesoderm induction in the ES cell
model. Although Flk1 is expressed on all posterior mesoderm,
it is found only on a subpopulation of other mesodermal cells,
indicating that is it not a general mesodermal marker (Ema
et al., 2006).Stage 2: From PS to Flk1+ Hematopoietic Mesoderm
The above studies suggest that BMP4, but not low levels of
Wnt3a and Activin A, can induce the development of Flk1 meso-
derm when added to the cultures at the onset of differentiation.
These findings also indicate that BMP4 likely exerts its effect at
a stage later than induction of the PS, as it is not required for
the development of this population. To further dissect the role
of Wnt, Activin/Nodal, and BMP signaling in Flk1 mesoderm in-
duction from the brachyury-positive PS population, we isolated
GFP-Bry+/Flk1 cells from Activin A/Wnt3a-induced cultures
and reaggregated them with different combinations of the three
factors with or without inhibitors of these pathways (Figure 4A).
The optimal dose of each factor in inducing Flk1 and hematopoi-
etic commitment were determined by titration (data not shown).
The levels of Flk1 were measured after 1 additional day of cul-
ture, and hematopoietic potential was assayed as follows. After
reaggregation for 1 day, the aggregates were harvested,
washed, and cultured in the presence of VEGF for an additional
2 days (Figure 4A). Treatment with VEGF, the ligand for Flk1, has
been shown to be important for hematopoietic development
from Flk1+ mesoderm (Park et al., 2004). After culture with
VEGF, hematopoietic commitment was assayed by expression
of CD41, a marker of embryonic hematopoietic commitment
(Ferkowicz et al., 2003; Mikkola et al., 2003). In this way, meso-
dermal commitment can be assayed by Flk1 upregulation, and
the hematopoietic potential of the Flk1+ population can be ana-
lyzed by CD41 upregulation upon VEGF treatment.
In the first set of analyses, Activin A, BMP4, or high levels of
Wnt3a were tested alone for their ability to induce the develop-
ment of Flk1+ cells from the GFP-Bry+/Flk1 population. Activin
A induced a population in which 50% of the cells expressed Flk1
after 24 hr of culture and 25% expressed CD41 after 48 hr of
VEGF treatment (Figures 4B and 4C). BMP4 or high levels of
Wnt3a alone were considerably less efficient at inducing Flk1
and CD41 expression, with 20% of the cells expressing Flk1
(Figure 4B) and less than 10% expressing CD41 (Figure 4C).
To determine if BMP or Wnt signaling is required for the Activin
A-induced expression of Flk1, inhibitors of these pathways
were included in the cultures. In combination with Activin A,
the Wnt inhibitor DKK1 completely blocked Flk1 expression,
whereas the BMP inhibitor decreased its expression by more
than 3-fold (Figure 4B). Both inhibitors completely blocked the
upregulation of CD41 (Figure 4C). These data suggest that mul-
tiple pathways are involved in Flk1 hematopoietic mesoderm in-
duction. To further investigate this hypothesis, combinations of
the three factors were used to induce Flk1 and CD41 expression
(Figures 4B and 4C). The combination of Wnt3a and BMP4 was
not more effective than either factor alone. In contrast, Activin ABMP4 (0.3 ng/ml), Activin A (2 ng/ml), DKK1 (300 ng/ml), Wnt3a (50 ng/ml), SB-431542 (6 mM), and BMPR1A-Fc plus BMPR1B-Fc (500 ng/ml each) or combi-
nations of these factors as indicated.
(B) Flow cytometric analysis showing the average proportion of cells that express Flk1 after 24 hr of culture ± SEM (n = 6).
(C) Cells treated as in (B) were washed in serum-free media and cultured for 2 additional days in the presence of VEGF (5 ng/ml) to induce hematopoietic
development. The average proportion of cells that express CD41 was determined by flow cytometry.
(D–H) Cells were harvested, and gene expression analysis was performed by quantitative RT-PCR. Average expression normalized to actb is shown. Number on
vertical axis represents relative expression levels. (D) Expression of bmp4, bmp2, and chrd in the GFP-Bry+/Flk1 cells after 24 hr of culture in the presence (Rg1;
Act) or absence (Rg1;Stim) of Activin A (from [B] above) or in day 4 EBs induced withWnt3a and Activin A as in Figure 3A. (E–H) Expression of gata1, scl,meox1,
and nkx2.5 in the populations stimulated with different factors (from [C] above). Errors bars indicate ± SEM (n = 6, [B] and [C]) (n = 3, [D] and [E]). (Act, Activin A; R,
BMPR1A-Fc and BMPR1B-Fc; Rg, reaggregation; SB, SB-431542; and Stim, minus stimulation).Cell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc. 65
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robust Flk1 (>60%) and CD41 expression (60%). The CD41
expression levels were more than 2-fold above that observed
with Activin A alone (Figure 4C). Taken together, these results
strongly support the interpretation that all three pathways are im-
portant for the development of Flk1 hematopoietic mesoderm
from GFP-Bry+ PS-like cells.
Considering the inability of Activin A and low levels of Wnt3a
to induce Flk1 when added to the cultures at the onset of differ-
entiation (Figure 3A), it is somewhat surprising that Activin A
alone displayed this potential on the GFP-Bry+/Flk1 population
(Figure 4B). Our earlier studies demonstrated that BMP4 is an
important regulator of Flk1 induction, when added prior to the
induction of the PS. The differences in the ability of Activin A to
generate Flk1+ cells could relate to the endogenous levels of
BMPs and/or BMP inhibitors in the two populations after induc-
tion. A comparison of the expression levels of bmp2, bmp4, and
the BMP inhibitor chrd in the GFP-Bry+/Flk1-reaggregated cul-
tures with or without Activin A and the day 4 Activin A-induced
PS population described in Figure 3A revealed interesting differ-
ences consistent with this interpretation. As shown in Figure 4D,
Activin A induced the expression of bmp2 and bmp4 and in-
hibited the expression of chrd in the reaggregation cultures. In
contrast, the expression of chrd was higher in the day 4 PS pop-
ulation than in the GFP-Bry+/Flk1-reaggregated cells, whereas
the levels of bmp2 and bmp4were lower. These findings suggest
that the differential response to Activin A may be due to differen-
tial upregulation of the BMP factors and chrd in the two popula-
tions. They also highlight the importance of analyzing distinct de-
velopmental intermediates when defining the signaling pathway
requirements for a complex developmental program.
To further characterize the mesodermal populations gener-
ated by the different inducers, the cultures were evaluated for
the expression of gata1 (Pevny et al., 1991) and scl (Begley
et al., 1989) as an additional demonstration of hematopoietic po-
tential, the expression ofmeox1 as an indication of somitic spec-
ification (Candia et al., 1992), and nkx2.5 to track early cardiac
development (Lints et al., 1993). As expected, gata1 and scl dis-
played expression patterns very similar to that of CD41, with
the highest levels detected in the Activin A plus Wnt3a and/or
BMP-stimulated populations (Figures 4E and 4F). The patterns
ofmeox1 and nkx2.5 were distinct from those of the hematopoi-
etic genes.meox1 expression was highest in the Wnt3a and the
unstimulated populations, whereas nkx2.5was induced at higher
levels in the Activin A and BMP4-stimulated populations (Figures
4G and 4H). Together, these findings demonstrate that Activin A
together with BMP and/or Wnt signaling efficiently induces he-
matopoietic mesoderm from the GFP-Bry+/Flk1 PS population.
Individual factors such asWnt3a or BMP4 appear to promote the
specification of other cell fates.
Stage 3: Specification of Flk1+ Mesoderm
to the Hematopoietic Lineage
The findings from the previous set of experiments demonstrate
that Flk1+ mesodermal progenitors induced with the combina-
tion of Activin A and Wnt3a or BMP4 are highly enriched for cells
with hematopoietic potential (Figure 4). Although these three
pathways are important to induce Flk1+ cells that can respond
to VEGF and generate CD41+ cells, their role in the hemato-66 Cell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc.poietic specification from the Flk1+ mesodermal cells is not
known.
To determine if individual factors can induce the progression
of Flk1+ mesoderm to the hematopoietic lineage, Flk1+ cells
were isolated by cell sorting and reaggregated with different fac-
tors from 1 to 3 days. To avoid multiple cell sorting steps, the ES
cells were induced with the combination of Activin A, BMP4, and
Wnt3a. By day 4, 90% of the cells within the EBs expressed
GFP-Bry, and of these, 50% expressed Flk1 (data not shown).
At this stage, GFP-Bry+/Flk1+ cells were sorted and assayed
for hematopoietic colony-forming ability in methylcellulose.
This GFP-Bry+/Flk1+ population did not give rise to any hemato-
poietic colonies when plated directly into methylcellulose (data
not shown). When reaggregated in the presence of VEGF for 1
or more days, the GFP-Bry+/Flk1+ population acquired the po-
tential to generate hematopoietic colonies. As shown in
Figure S2, the highest number of primitive erythroid colonies
was obtained from aggregates exposed to VEGF for 2 days.
Given these observations, all subsequent analyses were carried
out on cells aggregated for 2 days in the presence of different
factors. In the absence of VEGF, the addition of either Activin
A, BMP4, or Wnt3a did not lead to significant hematopoietic col-
ony formation (Figure 5A). In addition, only treatment with VEGF
prevented significant cell death (Figure S3). These data indicate
that VEGF has an important role in hematopoietic specification
and/or survival that cannot be substituted by Activin A, BMP4,
or Wnt3a. Relative colony numbers per 10,000 cells plated are
shown in Figure S4; these results are very similar to the total
colonies per culture shown in Figure 5.
Although the findings above indicate that treatment with VEGF
alone can lead to hematopoietic progenitor formation, endoge-
nous Activin/Nodal, BMP, or Wnt secreted by the cells in culture
may also play a role. To define the requirement of these path-
ways in the context of VEGF stimulation, inhibitors of Activin/
Nodal, BMP, and Wnt were used in combination with VEGF dur-
ing the reaggregation of Flk1+ mesodermal cells. The addition of
DKK1, SB, and BMPRs to the VEGF-induced population did not
significantly impact the frequency (Figure S4B) or total number of
definitive hematopoietic progenitors that developed (Figure 5B).
In contrast, primitive erythroid colony formation was completely
blocked by the addition of these inhibitors. To determine which
pathway was responsible for the block in primitive erythroid
development, Flk1+ cells were reaggregated with VEGF plus
each individual inhibitor of Activin/Nodal, BMP, or Wnt signaling.
Addition of DKK1 completely blocked primitive erythroid devel-
opment. The frequency and total number of definitive colony pro-
genitors were also reduced compared to the VEGF-treated
group; however, the observed reduction was not statistically sig-
nificant (Figure S4B and Figure 5B). The addition of SB to block
Activin/Nodal signaling or soluble BMPRs to block BMP signal-
ing had no effect on either primitive or definitive colony forma-
tion. These results suggest that the maturation of Flk1+ meso-
derm into cells capable of forming definitive hematopoietic
colonies is independent of Activin/Nodal, BMP, and Wnt signal-
ing while primitive erythropoiesis has an absolute requirement
for canonical Wnt signaling.
The addition of Activin A or Wnt3a together with VEGF consis-
tently resulted in an increase in both the frequency (Figure S4C)
and total number (Figure 5C) of primitive erythroid progenitors.
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(A–C) GFP-Bry+/Flk1+ cells were isolated by cell sorting from day 4 EBs differentiated with Activin A (2 ng/ml), Wnt3a (3–5 ng/ml), and BMP4 (0.3 ng/ml). These
mesoderm cells were reaggregated and cultured for 2 days with VEGF (5 ng/ml), BMP4 (0.3 ng/ml), Activin A (2 ng/ml), DKK1 (300 ng/ml), Wnt3a (50 ng/ml),
SB-431542 (6 mM), and BMPR1A-Fc plus BMPR1B-Fc (500 ng/ml each) or combinations of these factors as indicated. Methylcellulose hematopoietic colony
assays were performed on each population after 2 days of culture. Primitive erythroid (550 per 10,000 cells in VEGF treated) and definitive hematopoietic
(both myeloid and erythroid combined; 550 per 10,000 cells in VEGF treated) total colony numbers per treatment were determined. All data are normalized
to the VEGF-treated cells. (A) Culture with individual factors or inhibitors. (B) Culture with VEGF plus inhibitors as indicated. (C) Culture with VEGF plus inducers
as indicated.
(D) Flk1+ cells isolated from Activin A, Wnt3a, and BMP4-induced EBs generated from the A2lox.sbcat ES cell line were cultured for 2 days with VEGF in the
presence and absence of doxycycline and/or DKK1. Methylcellulose hematopoietic colony assays were performed as above. Numbers shown are normalized
to the uninduced control.
Errors bars indicate ± SEM (n = 4, [A]–[C]) (n = 3, [D]) (**p value < 0.0004, *p value < 0.05). (Act, Activin A; R, BMPR1A-Fc and BMPR1B-Fc; Def, definitive
hematopoietic colonies; Dox, doxycycline; Prim, primitive erythrocyte colonies; SB, SB-431542; Stim, minus stimulation; and V, VEGF).Although the increase in total numbers did not reach statistically
significant levels, the change in the frequency of progenitors in-
duced with Wnt3a and VEGF was significant (Figure S4C). The
addition of BMP4 did not significantly impact the number of
primitive erythroid progenitors. None of the factors significantly
altered the frequency or total number of definitive progenitors.
Taken together, these findings indicate that Wnt signaling in
the Flk1+ population is absolutely required in primitive erythroid
development, whereas Activin/Nodal and BMP signaling are
dispensable.
To confirm the importance of Wnt signaling on specification of
the primitive erythroid lineage from Flk1+ mesoderm, the canon-ical Wnt pathway was induced in an ES cell line that overex-
presses a stabilized form of b-catenin in a doxycycline-inducible
manner (Lindsley et al., 2006). Induction of b-catenin (+Dox) in the
Flk1+cells reaggregated in thepresenceofVEGF resulted inmore
than a 3-fold increase in the frequency and total number of prim-
itive erythroid progenitors compared to uninduced Flk1+ cells
reaggregated in the presence of VEGF alone (Figure S4D and
Figure 5D). The induction of b-catenin had no effect on the spec-
ification of the definitive lineages. Expression of the stabilized
b-cateninwas also able to reverse the block in primitive erythroid
development mediated by DKK1, indicating that these inhibitory
effects onspecificationof theprimitive erythroid lineageweredueCell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc. 67
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with those in the Wnt3a or DKK1-treated cultures and further
demonstratea role for canonicalWnt signaling in the specification
of the primitive erythroid lineage from Flk1+ mesoderm.
DISCUSSION
During embryogenesis, development is controlled by the con-
certed actions ofmany signaling pathways that function together
to specify a given cell fate. To understand the molecular mecha-
nisms driving differentiation, it is essential to examine the com-
plexities of these interactions on isolated populations that repre-
sent distinct stages of development. The ES cell differentiation
system is well suited to this approach, as it provides access to
such populations and it is amenable to the activation and sup-
pression of multiple pathways at once using appropriate ago-
nists and antagonists. Taking advantage of the power of this
model, we have investigated the roles of Activin/Nodal, BMP,
andWnt signaling at distinct stages along the differentiation pro-
gram of ES cells to blood. The outcome of these studies has pro-
vided a basic understanding of the factors regulating different
developmental steps and in doing so has uncovered a role for
Wnt signaling in the specification of the primitive erythroid line-
age (Figure 6).
Studies using mouse mutants have demonstrated an essen-
tial role for nodal and Wnt signaling at the earliest stages of pri-
mary germ layer formation, as nodal/ and wnt3/ embryos
all fail to gastrulate (Conlon et al., 1994; Liu et al., 1999). A sim-
ilar requirement for these pathways in gastrulation and germ
layer specification was demonstrated in both zebrafish and
Xenopus (Feldman et al., 1998; Jones et al., 1995; Vonica
and Gumbiner, 2002). In contrast to these pathways, the role
of BMP signaling in PS formation is less clear. Although muta-
tions in bmp4, bmpr1a, or bmpr2 all compromise gastrulation
to some extent (Beppu et al., 2000; Mishina et al., 1995; Win-
nier et al., 1995), inactivation of bmpr1a specifically in the epi-
blast does not disrupt PS formation (Miura et al., 2006). Our
previous studies with the ES cell system demonstrated that
Wnt and Activin/Nodal are essential for the establishment of
the PS in culture, indicating that regulation of key developmen-
tal events is recapitulated in this model (Gadue et al., 2006).
The findings presented in this report show that BMP signaling
is not essential for the induction of the in vitro PS-like popula-
tion. BMP4 was found to induce a brachyury expressing PS
population, but it does so indirectly, through the endogenous
activation of the Nodal and Wnt pathways. A similar scenario
may take place in vivo where BMP signaling from the extraem-
Figure 6. Schematic Representation of
Hematopoietic Development during ES
Cell Differentiation Summarizing the Role
of the Different Signaling Pathways Identi-
fied in This Study
bryonic ectoderm may be required to ini-
tiate the Wnt and Nodal pathways. Dis-
ruption of signaling at this stage would
significantly impact gastrulation. Once
Nodal and Wnt3 are induced, however, gastrulation could pro-
ceed in the absence of BMP, as observed in the epiblast-spe-
cific bmpr1a-deficient animals. Although BMP is not required
for the development of the PS-like population in vitro, it does
exert a ‘‘dominant posteriorizing’’ effect as demonstrated by
the inhibition of the development of the Activin A-induced ante-
rior PS population. These findings are consistent with studies in
the mouse embryo that revealed that inhibitors of BMP signal-
ing are expressed in the region of the anterior PS (Beddington
and Robertson, 1999).
To track the establishment of hematopoietic mesoderm from
the PS, we monitored the development of Flk1+ and CD41+ pop-
ulations and the upregulation of scl and gata1. Flk1 was initially
identified as a marker of the vascular lineage (Yamaguchi
et al., 1993). Subsequent studies demonstrated that this recep-
tor is expressed on posterior mesoderm, on the hemangioblast,
and on the earliest hematopoietic and vascular progenitors (Choi
et al., 1998; Huber et al., 2004; Kabrun et al., 1997). Lineage trac-
ing experiments and marker analyses indicated that the expres-
sion of Flk1 extends beyond the hematopoietic and vascular sys-
tem and demonstrated that it is expressed at early stages during
the patterning of cardiac and somitic mesoderm (Ema et al.,
2006; Motoike et al., 2003). In this report, we showed that Flk1
expression is associated with establishment of the mesoderm
fate, as Flk1+ cells could no longer generate endoderm after Ac-
tivin A treatment. Using the GFP-Bry+/Flk1 PS cells as a target
population, we show that the optimal induction of Flk1+ hemato-
poietic mesoderm required the combination of Activin/Nodal,
Wnt, and BMP signaling. In contrast, stimulation with either
Activin A or BMP4 alone resulted in the upregulation of nkx2.5,
indicative of cardiac development, whereas unstimulated or
Wnt3a-induced cultures led to the expression of meox1, a
gene associated with somitic mesoderm development. These
findings are consistent with the above lineage tracing studies,
which show that Flk1+ cells can contribute to many mesodermal
lineages, including skeletal muscle and heart (Ema et al., 2006;
Motoike et al., 2003).
A comparison of the regulation of induction of Flk1 from the PS
cells to that of the prestreak epiblast-like population revealed in-
teresting and important differences. BMP4 appeared to be more
efficient at upregulating Flk1 when added to the day 2 epiblast-
like population compared to the induction from GFP-Bry+/Flk1
PS-like cells. Park et al. also observed that BMP4 alone could in-
duce Flk1 expression when included in the cultures early during
the differentiation protocol (Park et al., 2004). Although BMP4
was effective in Flk1 induction from early stage cells, our gene
expression analyses and inhibitor studies indicate that it68 Cell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc.
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nodal, suggesting that all three pathways are involved. The low
levels of Flk1 expression induced by BMP4 from the PS (GFP-
Bry+) cells may reflect a reduced ability to induce the other path-
ways in this population. The reverse pattern was observed with
Activin A, which was considerably more effective at inducing
Flk1 from the PS-like population than from the early epiblast-
like cells. In this case, the differential effects appear to be asso-
ciated with the relative levels of endogenous bmp4, bmp2, and
the BMP inhibitor chrd. These observations demonstrate that
the environment within the developing EBs changes with time
and highlight the importance of examining the role of signaling
pathways on isolated populations rather than on intact EBs.
The cytokine environments that are established within the EBs
during these early developmental stages may reflect a certain
level of spatial organization of the developing populations within
these structures. Support for this interpretation is provided by in
situ hybridization analysis demonstrating that brachyury ex-
pressing cells are distributed throughout the developing EBs,
whereas those expressing Flk1 are located at the outer edge of
the EB (Robertson et al., 2000). Although the significance of
this spatial segregation is presently unclear, it may play a role
in determining the factors that are produced and the populations
that are induced within intact EBs.
The analysis of the final step, the specification of Flk1+ meso-
derm to a hematopoietic fate, uncovered a role for Wnt signaling
in the establishment of the primitive erythroid lineage. Although
considerable effort has been directed at understanding the reg-
ulation and maturation of the definitive hematopoietic program
(Baron and Fraser, 2005), little is known about the signaling path-
ways that regulate primitive erythropoiesis. Our studies using
the Wnt inhibitor, Wnt3a, and the inducible activated b-catenin
expressing ES cell line clearly demonstrate that activation of
a b-catenin signaling pathway is essential for the establishment
of the primitive, but not the definitive, hematopoietic lineage. Al-
though comparable stage-specific evaluation of these signaling
pathways is difficult, if not impossible, in the early embryo, the
expression of Wnt3, Wnt3a, and Wnt8a in the posterior PS and
the early yolk sac suggests that Wnt signaling may play a similar
role in the establishment of the primitive erythroid lineage in vivo
(Yamaguchi, 2001). The role of Wnt in hematopoietic commit-
ment has not been investigated in any detail. In contrast to
Wnt, BMP signaling does not appear to be required for hemato-
poietic specification of Flk1 mesoderm. This finding is consistent
with recent in vivo studies demonstrating that deletion of bmpr1a
in Flk1 expressing cells had no effect on hematopoiesis (Park
et al., 2006). Although a compensatory role of other type 1 recep-
tors could not be excluded in these in vivo studies, our ability to
inhibit all BMP signaling with the soluble receptors BMPR1A and
1B strongly suggests that this pathway is not required for hema-
topoietic specification.
In summary, the findings presented in this study establish
a roadmap of the minimal signaling pathways that regulate
the developmental progression from ES cells to the hematopoi-
etic lineage. By evaluating multiple pathways on isolated pop-
ulations representing distinct stages of development, we were
able to define stage-specific roles for these different pathways
and uncover a role for Wnt signaling in the specification of the
primitive erythroid lineage. The approach used and the out-come of this study highlight the strengths of the ES cell model
for investigating primary germ layer induction and specification
and establish a platform for future studies aimed at gaining
a more detailed understanding of these and other developmen-
tal programs.
EXPERIMENTAL PROCEDURES
ES Cell Maintenance and Differentiation
The GFP-Bry/CD4-Foxa2 ES cells were maintained in a modified serum-free/
feeder-free culture system (Gadue et al., 2006; Ying et al., 2003) and differen-
tiated in a serum-free media as described previously (Gadue et al., 2006). In
brief, ES cells were trypsinized and cultured in serum-free differentiationmedia
without any additional growth factors to form EBs for 48 hr. At this stage, the
EBs were dissociated with trypsin and reaggregated in serum-free differentia-
tionmedia with the addition of various growth factors or inhibitors as indicated.
In most experiments, the EBs were harvested 2 days later (total of 4 days of
differentiation), the cells dissociated, and then appropriate populations were
isolated by cell sorting. For reaggregation, sorted cells were cultured at
250,000 cells/ml in low-cluster dishes (Costar). The ES line A2lox.sbcat, con-
taining a stabilized b-catenin gene under control of a doxycycline-regulated
promoter (Lindsley et al., 2006), was adapted to serum-free/feeder-free cul-
ture. These cells were differentiated as described above, with the exception
that the initial stage of EB formation in the absence of growth factors was
shorted from 48 to 24 hr and DKK1 was added after 6 hr of reaggregation to
allow time for the doxycycline induction of b-catenin. Human Activin A, human
BMP4,mouse BMPR1A-Fc, mouse BMPR1B-Fc, human DKK1, human VEGF,
and mouse Wnt3a were purchased from R&D systems, and SB-431542 was
obtained from Tocris.
RT-PCR and Quantitative Real-Time PCR
Total RNA was prepared with the RNeasy mini or micro kits (QIAGEN) and
treated with RNase-free DNase (QIAGEN). One-hundred nanograms to 1 mg
RNA was reverse transcribed into cDNA by using random hexamers with
Superscript II Reverse Transcriptase (Invitrogen). PCR was performed with
Taq polymerase (Promega) or Platinum Taq (Invitrogen). Real-time quantitative
PCR was performed on a MasterCycler EP RealPlex (Eppendorf) or the ABI
7900HT (Applied Biosystems). All experiments were done in triplicate with
Platinum SYBRGreen qPCR SuperMix or SYBRGreenER qPCR SuperMix (In-
vitrogen). The oligonucleotide sequences and PCR cycle conditions are listed
in the supporting text (Table S1). A 10-fold dilution series of mouse genomic
DNA standards ranging from 50 ng/ml to 5 pg/ml was used to evaluate the effi-
ciency of the PCR and calculate the copy number of each gene relative to the
house keeping gene Actb.
Flow Cytometry and Cell Sorting
EBs generated from the ES cell differentiations were dissociated by incubation
with trypsin for 1–2min and stained for the following cell surface antigens: anti-
mouse CD41-Alexa 647 (1B5), anti-mouse Flk1-biotin, anti-mouse CD31-phy-
coerythrin (PharMingen), anti-human CD4-phycoerythrin or -allophycocyanin
(Caltag), and streptavidin-allophycocyanin or -phycoerythrin (PharMingen).
To assess Smad1/5 phosphorylation, intracellular staining was performed as
described previously (Krutzik and Nolan, 2003). In short, day 4 EBs treated
as indicated in the text were dissociated with trypsin/EDTA, and the resulting
single cells were fixed with 1.6% paraformaldehyde for 10 min at 37C and
permeabilized with 90% ice-cold methanol for 20min. Staining was performed
with rabbit monoclonal anti-phospho-smad1/5 or anti-GST as a control (Cell
Signaling Technologies) and revealed with F(ab0)2 Donkey anti-rabbit IgG-
phycoerythrin (Jackson ImmunoResearch). The cells were acquired with a
LSR II or FACSCalibur flow cytometer (Becton Dickenson) or sorted on aMoFlo
(Cytomation Systems) or FACSVantage (Becton Dickenson) cell sorter. Analy-
sis was performed with FlowJo software (Tree Star Inc.).
Hematopoietic Progenitor Assay
For the hematopoietic progenitor assay, EBs induced under various con-
ditions were dissociated by trypsin to a single-cell suspension and plated in
methylcellulose containing hematopoietic growth factors as describedCell Stem Cell 2, 60–71, January 2008 ª2008 Elsevier Inc. 69
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morphology: primitive erythrocyte, definitive erythrocyte, macrophage, eryth-
rocyte-macrophage, erythrocyte-megakaryocyte, granulocyte-macrophage,
and mixed colonies containing at least three cell types. Colony numbers
were normalized to the VEGF-treated group, and the mean and standard er-
rors of the mean of four independent experiments were calculated. ANOVA
statistical analysis was used to evaluate the significance among the different
groups. The Bonferroni/Dunn correction factor was applied to the statistical
analysis, which restricted our level of significance to p values below 0.0004. Ex-
periments using the A2lox.sbcat ES cell line were analyzed with a Student’s
t test.
Supplemental Data
Supplemental Data include four figures and one table and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/2/1/
60/DC1/.
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